Nipent and cough Patient Reports February 13, 2012
Nipent Side Effects Report #5038658-9
Nipent side effect was reported by a Consumer or non-health professional from ITALY on June 07, 2006. Male patient, 39 years of age, was diagnosed with t-cell lymphoma and was treated with Nipent. After drug was administered, patient experienced the following side effects: blood culture positive, bronchopulmonary aspergillosis, chest pain
, cough, cytomegalovirus test positive, fungal infection
, hepatomegaly, hyperpyrexia, jaundice
. Nipent dosage: 5 MG/M2, DAY 1-3. Patient died.Nipent Side Effects Report #5858929-3
Nipent side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 12, 2008. Male patient, 67 years of age, weighting 215.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, asthenia, blood pressure systolic decreased, cardiomegaly, chronic lymphocytic leukaemia, confusional state, cough, diarrhoea, disease progression. Nipent dosage: 4 MG/M2. During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE, PREDNISONE. Patient was hospitalized. Patient died on 01/26/2006.
Nipent Side Effects Report #5613734-8
Nipent side effect was reported by a Physician from UNITED STATES on Jan 18, 2008. Male patient, 63 years of age, weighting 231.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: blepharitis, blood bicarbonate increased, blood chloride increased, blood creatinine increased, blood culture positive, blood urea increased, bronchospasm, cough, dehydration. Nipent dosage: 4 MG/M2 Q12DAYS IV. During the same period patient was treated with RITUXAN, CYTOXAN, GLUCOPHAGE, GLUCOTROL, AVALIDE, TRICOR, NEURONTIN, PROCRIT. Patient was hospitalized. Patient recovered.
Nipent Side Effects Report #4700213-5
Nipent side effect was reported by a Consumer or non-health professional from on June 15, 2005. Male patient, 63 years of age, weighting 231.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: blepharitis, cough, dehydration, febrile neutropenia, gastroenteritis
, pleural effusion, wheezing. Nipent dosage: 0.1905 MG/M2 (4 MG/M2, Q 21 DAYS), INTRAVENOUS. During the same period patient was treated with RITUXAN, CYTOXAN. Patient was hospitalized. Patient recovered.
Nipent and cough 